In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zhejiang Hisun Pharmaceutical Co. Ltd.

www.hisunpharm.com

Latest From Zhejiang Hisun Pharmaceutical Co. Ltd.

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply medical products to fight the coronavirus around the world, a battle to banish its image of poor product quality is on.

Quality Regulation

India COVID-19 Update: Antivirals, Eyes On HCQ-Azithromycin Data

Development work for antivirals such as favipiravir and remdesivir seen as potential treatments for coronavirus is underway in India, with the former’s off-patent status making it more attractive. All eyes are also on data from a French study which highlights the potential of hydroxychloroquine and azithromycin as a COVID-19 treatment.

Research & Development Coronavirus COVID-19

Some Caution Over 'People’s Hope' Remdesivir As China Trials Progress

Although Gilead’s remdesivir shows promise against the coronavirus, efficacy is not guaranteed, one antiviral company executive tells Scrip, as multiple other potential therapies and vaccines move forward.

Coronavirus COVID-19 Clinical Trials

China Coronavirus Approvals: Fast, Free And Fine?

A lack of Emergency Use Authorization potentially jeopardizes China’s efforts to fight the deadly virus outbreak, says a regulatory veteran.

Coronavirus COVID-19 Regulation
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Zhejiang Hisun Pharmaceutical Co. Ltd.
  • Senior Management
  • Bai Hua, Pres. & CEO
  • Contact Info
  • Zhejiang Hisun Pharmaceutical Co. Ltd.
    Phone: (86) 4001180618
    46 Waisha Rd., Jiaojiang District
    Taizhou City,
    China
UsernamePublicRestriction

Register